Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021.
Thompson MG, Burgess JL, Naleway AL, Tyner HL, Yoon SK, Meece J, Olsho LEW, Caban-Martinez AJ, Fowlkes A, Lutrick K, Kuntz JL, Dunnigan K, Odean MJ, Hegmann KT, Stefanski E, Edwards LJ, Schaefer-Solle N, Grant L, Ellingson K, Groom HC, Zunie T, Thiese MS, Ivacic L, Wesley MG, Lamberte JM, Sun X, Smith ME, Phillips AL, Groover KD, Yoo YM, Gerald J, Brown RT, Herring MK, Joseph G, Beitel S, Morrill TC, Mak J, Rivers P, Harris KM, Hunt DR, Arvay ML, Kutty P, Fry AM, Gaglani M. Thompson MG, et al. Among authors: edwards lj. MMWR Morb Mortal Wkly Rep. 2021 Apr 2;70(13):495-500. doi: 10.15585/mmwr.mm7013e3. MMWR Morb Mortal Wkly Rep. 2021. PMID: 33793460 Free PMC article.
Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label Trial.
Dawood FS, Naleway AL, Flannery B, Levine MZ, Murthy K, Sambhara S, Gangappa S, Edwards L, Ball S, Grant L, Belongia E, Bounds K, Cao W, Gross FL, Groom H, Fry AM, Rentz Hunt D, Jeddy Z, Mishina M, Kim SS, Wesley MG, Spencer S, Thompson MG, Gaglani M. Dawood FS, et al. Clin Infect Dis. 2021 Dec 6;73(11):1973-1981. doi: 10.1093/cid/ciab566. Clin Infect Dis. 2021. PMID: 34245243 Free PMC article. Clinical Trial.
Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers.
Yoon SK, Hegmann KT, Thiese MS, Burgess JL, Ellingson K, Lutrick K, Olsho LEW, Edwards LJ, Sokol B, Caban-Martinez AJ, Schaefer-Solle N, Jones JM, Tyner H, Hunt A, Respet K, Gaglani M, Dunnigan K, Rose S, Naleway A, Groom H, Kuntz J, Fowlkes AL, Thompson MG, Yoo YM; HEROES-RECOVER Network Investigators; HEROES-RECOVER Network Investigators. Yoon SK, et al. Among authors: edwards lj. N Engl J Med. 2022 May 12;386(19):1855-1857. doi: 10.1056/NEJMc2201821. Epub 2022 Apr 6. N Engl J Med. 2022. PMID: 35385628 Free PMC article. No abstract available.
Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label Trial.
Gaglani M, Kim SS, Naleway AL, Levine MZ, Edwards L, Murthy K, Dunnigan K, Zunie T, Groom H, Ball S, Jeddy Z, Hunt D, Wesley MG, Sambhara S, Gangappa S, Grant L, Cao W, Gross FL, Mishina M, Fry AM, Thompson MG, Dawood FS, Flannery B. Gaglani M, et al. Clin Infect Dis. 2023 Feb 8;76(3):e1168-e1176. doi: 10.1093/cid/ciac683. Clin Infect Dis. 2023. PMID: 36031405 Free PMC article. Clinical Trial.
Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccines.
Liu F, Gross FL, Joshi S, Gaglani M, Naleway AL, Murthy K, Groom HC, Wesley MG, Edwards LJ, Grant L, Kim SS, Sambhara S, Gangappa S, Tumpey T, Thompson MG, Fry AM, Flannery B, Dawood FS, Levine MZ. Liu F, et al. Among authors: edwards lj. Nat Commun. 2024 Jan 4;15(1):254. doi: 10.1038/s41467-023-44551-x. Nat Commun. 2024. PMID: 38177116 Free PMC article. Clinical Trial.
Randomised immunogenicity trial comparing 2019-2020 recombinant and egg-based influenza vaccines among frequently vaccinated healthcare personnel in Israel.
Fowlkes AL, Peretz A, Greenberg D, Hirsch A, Martin ET, Levine MZ, Edwards L, Radke S, Lauring AS, Ferdinands JM, Zhang C, Yoo YM, Dreiher J, Newes-Adeyi G, Azziz-Baumgartner E, Fry AM, Monto AS, Balicer R, Thompson MG, Katz MA. Fowlkes AL, et al. Int J Infect Dis. 2024 Oct 10;149:107260. doi: 10.1016/j.ijid.2024.107260. Online ahead of print. Int J Infect Dis. 2024. PMID: 39395753 Free article.
CREST-2 Reaches A Surgical Milestone.
Lal BK, Brott TG, Edwards LJ, Meschia JF. Lal BK, et al. Among authors: edwards lj. J Vasc Surg. 2023 Oct 27:S0741-5214(23)02177-8. doi: 10.1016/j.jvs.2023.10.045. Online ahead of print. J Vasc Surg. 2023. PMID: 39491118 No abstract available.
Influenza Vaccine Effectiveness Against Illness and Asymptomatic Infection in 2022-2023: A Prospective Cohort Study.
White EB, Grant L, Mak J, Olsho L, Edwards LJ, Naleway A, Burgess JL, Ellingson KD, Tyner H, Gaglani M, Lutrick K, Caban-Martinez A, Newes-Adeyi G, Duque J, Yoon SK, Phillips AL, Thompson M, Britton A, Flannery B, Fowlkes A. White EB, et al. Among authors: edwards lj. Clin Infect Dis. 2024 Oct 24:ciae491. doi: 10.1093/cid/ciae491. Online ahead of print. Clin Infect Dis. 2024. PMID: 39446477
CREST-2 Reaches A Surgical Milestone.
Lal BK, Brott TG, Edwards LJ, Meschia JF. Lal BK, et al. Among authors: edwards lj. J Vasc Surg. 2024 Feb;79(2):195-197.e2. doi: 10.1016/j.jvs.2023.10.045. Epub 2023 Oct 29. J Vasc Surg. 2024. PMID: 39119201 Free PMC article. No abstract available.
219 results